Skip to content

Clinical trials

Phase 1 Respiratory Distress Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 1 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20071
20081
20111
20121
20131
20151
20171
20181
20204
20212
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Withdrawn4
Terminated3
Recruiting2
Unknown status2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital2
Altor BioScience1
Cartesian Therapeutics1
Denver Health and Hospital Authority1
Gregory Yanik1
HTIC, Inc1
Indiana University1
Lisata Therapeutics, Inc.1
Longeveron Inc.1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome22
Acute Lung Injury5
COVID-195
Sepsis3
Hypertension, Pulmonary2
Lung Diseases2
Respiratory Tract Diseases2
Apnea1
Bronchopulmonary Dysplasia1
Communicable Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.